In this study, we examined TNF-α levels in 34 healthy volunteers (HLT) and 99 patients, including 30 with subjective cognitive impairment (SCI) and 30 with mild cognitive impairment (MCI), which are considered preclinical stages that can evolve into AD [22], and 39 with AD (AD). Here, TNF is linked to Alzheimer disease.